A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
News|Slideshows|March 1, 2022
Acute Migraine Treatment: A Guide to Medication Options
Author(s)Grace Halsey
When choosing a migraine treatment for acute attack relief, the American Headache Society suggests following these steps.
Advertisement
To support primary care clinicians in diagnosis and management of migraine headache, the American Headache Society (AHS) has developed a turn-key virtual CME-accredited program that addresses topics from migraine epidemiology to patient selection for newly approved acute and preventive medications.
The following short overview is based on the AHS module on selecting an acute treatment, from First Contact: Headache in Primary Care .
Advertisement
Related to this article
Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.
Plasma p-tau217 levels helped estimate 5- and 10-year cognitive impairment risk in older adults without memory or thinking symptoms.
FDA cleared C2N’s PrecivityAD2 blood test to aid Alzheimer disease evaluation in symptomatic adults aged 40 years and older.
A Swedish observational study linked NOAC use to slower cognitive decline in individuals with atrial fibrillation and Alzheimer disease.
The FDA approved oveporexton for narcolepsy type 1 in adults, marking the first orexin receptor agonist targeting the underlying biological cause of narcolepsy.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
Advertisement
Advertisement
Trending on Patient Care Online
1
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
2
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
3
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
4
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
5